Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Aitziber Buqué, Norma Bloy, María Pérez-Lanzón, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Immunogenic cell stress and death
Guido Kroemer, Claudia Galassi, Laurence Zitvogel, et al.
Nature Immunology (2022) Vol. 23, Iss. 4, pp. 487-500
Open Access | Times Cited: 826
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Ilio Vitale, Efrat Shema, Sherene Loi, et al.
Nature Medicine (2021) Vol. 27, Iss. 2, pp. 212-224
Closed Access | Times Cited: 560
Mitochondrial control of inflammation
Saverio Marchi, Emma Guilbaud, Stephen W. G. Tait, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 159-173
Open Access | Times Cited: 524
Hallmarks of T cell aging
Marı́a Mittelbrunn, Guido Kroemer
Nature Immunology (2021) Vol. 22, Iss. 6, pp. 687-698
Closed Access | Times Cited: 379
Hallmarks of Health
Carlos López-Otı́n, Guido Kroemer
Cell (2020) Vol. 184, Iss. 1, pp. 33-63
Open Access | Times Cited: 372
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 309
Immunomodulation by targeted anticancer agents
Giulia Petroni, Aitziber Buqué, Laurence Zitvogel, et al.
Cancer Cell (2020) Vol. 39, Iss. 3, pp. 310-345
Open Access | Times Cited: 179
Emerging evidence for adapting radiotherapy to immunotherapy
Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 543-557
Closed Access | Times Cited: 155
ATP and cancer immunosurveillance
Oliver Kepp, Lucillia Bezu, Takahiro Yamazaki, et al.
The EMBO Journal (2021) Vol. 40, Iss. 13
Open Access | Times Cited: 153
Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Lisa Derosa, Bertrand Routy, Antoine Desîlets, et al.
Cancer Discovery (2021) Vol. 11, Iss. 10, pp. 2396-2412
Open Access | Times Cited: 121
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment
Safae Terrisse, Lisa Derosa, Valerio Iebba, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 9, pp. 2778-2796
Open Access | Times Cited: 118
NK cells and solid tumors: therapeutic potential and persisting obstacles
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 90
The DNA Damage Response and Inflammation in Cancer
Vanessa Klapp, Beatriz Álvarez-Abril, Giuseppe Leuzzi, et al.
Cancer Discovery (2023) Vol. 13, Iss. 7, pp. 1521-1545
Open Access | Times Cited: 54
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 45
Senescent CAFs mediate immunosuppression and drive breast cancer progression
Jiayu Ye, John Baer, Douglas V. Faget, et al.
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1302-1323
Closed Access | Times Cited: 28
Beneficial autoimmunity improves cancer prognosis
Laurence Zitvogel, Claude Perreault, Olivera J. Finn, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 9, pp. 591-602
Open Access | Times Cited: 81
NAD + Metabolism in Cardiac Health, Aging, and Disease
Mahmoud Abdellatif, Simon Sedej, Guido Kroemer
Circulation (2021) Vol. 144, Iss. 22, pp. 1795-1817
Open Access | Times Cited: 64
Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer
Safae Terrisse, Anne‐Gaëlle Goubet, Kousuke Ueda, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 3, pp. e004191-e004191
Open Access | Times Cited: 40
Bodywide ecological interventions on cancer
Guido Kroemer, Jennifer L. McQuade, Miriam Mérad, et al.
Nature Medicine (2023) Vol. 29, Iss. 1, pp. 59-74
Closed Access | Times Cited: 33
BCL2 Inhibition Reveals a Dendritic Cell–Specific Immune Checkpoint That Controls Tumor Immunosurveillance
Liwei Zhao, Peng Liu, Misha Mao, et al.
Cancer Discovery (2023) Vol. 13, Iss. 11, pp. 2448-2469
Open Access | Times Cited: 29
Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance
Léa Montégut, Peng Liu, Liwei Zhao, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Autophagy in the cancer-immunity dialogue
Takahiro Yamazaki, José Manuel Bravo‐San Pedro, Lorenzo Galluzzi, et al.
Advanced Drug Delivery Reviews (2020) Vol. 169, pp. 40-50
Open Access | Times Cited: 60
Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer
Giulia Petroni, Aitziber Buqué, Takahiro Yamazaki, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 7, pp. 1855-1863
Open Access | Times Cited: 54
TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients
Jana Raková, Iva Truxová, Peter Holíček, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 42
Science-Driven Nutritional Interventions for the Prevention and Treatment of Cancer
Léa Montégut, Rafael de Cabo, Laurence Zitvogel, et al.
Cancer Discovery (2022) Vol. 12, Iss. 10, pp. 2258-2279
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top